A Phase II Study of Combined Amivantamab, Carboplatin and Paclitaxel in Unresectable Locally Recurrent or Metastatic Head and Neck Cancer
Categories (click each to see list of all clinical trials associated with that category): Head & Neck (ONC)
Current Status: Not open
Phase: II
Principal Investigator: Abughanimeh, Omar
Eligibility: https://clinicaltrials.gov/study/NCT07062354?term=NCT07062354&rank=1
Summary